LLY

1,048.35

+0.39%↑

JNJ

244.4

-0.07%↓

ABBV

231.79

+2.18%↑

NVS

162.88

+0.85%↑

MRK

121.91

+1.37%↑

LLY

1,048.35

+0.39%↑

JNJ

244.4

-0.07%↓

ABBV

231.79

+2.18%↑

NVS

162.88

+0.85%↑

MRK

121.91

+1.37%↑

LLY

1,048.35

+0.39%↑

JNJ

244.4

-0.07%↓

ABBV

231.79

+2.18%↑

NVS

162.88

+0.85%↑

MRK

121.91

+1.37%↑

LLY

1,048.35

+0.39%↑

JNJ

244.4

-0.07%↓

ABBV

231.79

+2.18%↑

NVS

162.88

+0.85%↑

MRK

121.91

+1.37%↑

LLY

1,048.35

+0.39%↑

JNJ

244.4

-0.07%↓

ABBV

231.79

+2.18%↑

NVS

162.88

+0.85%↑

MRK

121.91

+1.37%↑

Search

Evolent Health Inc

Abierto

SectorSanidad

2.73 5

Resumen

Variación precio

24h

Actual

Mínimo

2.58

Máximo

2.7800000000000002

Métricas clave

By Trading Economics

Ingresos

30M

-21M

Ventas

35M

480M

Margen de beneficios

-4.351

Empleados

4,500

EBITDA

512K

15M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+183.88% upside

Dividendos

By Dow Jones

Próximas Ganancias

24 feb 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-463M

317M

Apertura anterior

-2.27

Cierre anterior

2.73

Noticias sobre sentimiento de mercado

By Acuity

43%

57%

141 / 352 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Very Strong Bullish Evidence

Evolent Health Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

12 feb 2026, 23:57 UTC

Acciones populares

Stocks to Watch: Applied Materials, Arista, DraftKings, Pinterest

12 feb 2026, 23:35 UTC

Ganancias
Principales Movimientos del Mercado

Arista Networks Surges on AI Networking Demand, Despite Rising Costs

12 feb 2026, 23:28 UTC

Ganancias

Applied Materials Profit Rises on Soaring AI Demand -- Update

12 feb 2026, 21:47 UTC

Ganancias

Vertex Pharmaceuticals Revenue Climbs on Continued Cystic Fibrosis Demand

13 feb 2026, 00:00 UTC

Charlas de Mercado

ANZ Gets a New Bull as Productivity Prospects Improve -- Market Talk

12 feb 2026, 23:47 UTC

Charlas de Mercado

Nikkei May Fall After AI Concerns Drag Stocks on Wall Street -- Market Talk

12 feb 2026, 23:38 UTC

Charlas de Mercado

Gold Steady; Could Undergo Technical Recovery -- Market Talk

12 feb 2026, 23:33 UTC

Ganancias

Coinbase Swings to a Fourth-Quarter Loss Amid Crypto Meltdown -- 2nd Update

12 feb 2026, 23:09 UTC

Charlas de Mercado

South32's Hermosa Review Stokes Spending Fears -- Market Talk

12 feb 2026, 22:55 UTC

Ganancias
Acciones populares

Applied Materials, DraftKings, Airbnb: Earnings in Focus -- WSJ

12 feb 2026, 22:46 UTC

Charlas de Mercado

Northern Star Outlook Needs Project Done On Time, In Budget -- Market Talk

12 feb 2026, 22:23 UTC

Ganancias

Coinbase Swings to a Fourth-Quarter Loss Amid Crypto Meltdown -- Update

12 feb 2026, 22:15 UTC

Ganancias

Agnico-Eagle Mines: Gold Production for 2026 and 2027, Expected at 3.3M to 3.5M Ounces Annually, Is Consistent With Previous Guidance, With Offsetting Adjustments Between Mine Sites >AEM.T

12 feb 2026, 22:15 UTC

Ganancias

Agnico-Eagle Mines Raises Dividend to 45c >AEM.T

12 feb 2026, 22:15 UTC

Ganancias

Agnico-Eagle Mines 4Q Rev $3.56B >AEM.T

12 feb 2026, 22:15 UTC

Ganancias

Agnico-Eagle Mines 4Q EPS $3.04 >AEM.T

12 feb 2026, 22:00 UTC

Ganancias

AGNICO EAGLE REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS - RECORD QUARTERLY AND ANNUAL FREE CASH FLOW; 2025 PRODUCTION GUIDANCE ACHIEVED; TOTAL 2025 SHAREHOLDER RETURNS OF $1.4 BILLION; DIVIDEND INCREASED BY 12.5%; UPDATED THREE-YEAR GUIDANCE >AEM.T

12 feb 2026, 22:00 UTC

Ganancias

Agnico-Eagle Mines 4Q Rev $3.56B >AEM

12 feb 2026, 22:00 UTC

Ganancias

Agnico-Eagle Mines 4Q Net $1.52B >AEM

12 feb 2026, 22:00 UTC

Ganancias

Agnico-Eagle Mines 4Q Adj EPS $2.70 >AEM

12 feb 2026, 22:00 UTC

Ganancias

AGNICO EAGLE REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS - RECORD QUARTERLY AND ANNUAL FREE CASH FLOW; 2025 PRODUCTION GUIDANCE ACHIEVED; TOTAL 2025 SHAREHOLDER RETURNS OF $1.4 BILLION; DIVIDEND INCREASED BY 12.5%; UPDATED THREE-YEAR GUIDANCE >AEM.T

12 feb 2026, 22:00 UTC

Ganancias

Agnico-Eagle Mines 4Q EPS $3.04 >AEM

12 feb 2026, 21:57 UTC

Ganancias

XP 4Q Rev BRL4.95B >XP

12 feb 2026, 21:52 UTC

Ganancias

Coinbase Revenue Falls Short as Crypto Market Sags -- Barrons.com

12 feb 2026, 21:50 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

12 feb 2026, 21:50 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

12 feb 2026, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

12 feb 2026, 21:47 UTC

Ganancias

Morningstar 4Q Rev $641M >MORN

12 feb 2026, 21:39 UTC

Ganancias

Coinbase Revenue Falls Short as Crypto Market Sags -- Barrons.com

12 feb 2026, 21:38 UTC

Ganancias

Howmet Stock Jumps. Earnings Show Strength For This Sector. -- Barrons.com

Comparación entre iguales

Cambio de precio

Evolent Health Inc previsión

Precio Objetivo

By TipRanks

183.88% repunte

Estimación a 12 Meses

Media 7.75 USD  183.88%

Máximo 10 USD

Mínimo 5 USD

De acuerdo con 10 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Evolent Health Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

10 ratings

9

Comprar

1

Mantener

0

Vender

Puntuación técnica

By Trading Central

10.33 / 10.95Soporte y Resistencia

Corto Plazo

Very Strong Bullish Evidence

Medio plazo

Very Strong Bullish Evidence

Largo Plazo

Weak Bearish Evidence

Sentimiento

By Acuity

141 / 352 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Evolent Health Inc

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.